{
    "eid": "2-s2.0-85149568526",
    "title": "Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "plant-produced recombinant protein",
        "SARS-CoV-2",
        "spike protein",
        "subunit vaccine"
    ],
    "authors": [
        "Chalisa Panapitakkul",
        "Narach Khorattanakulchai",
        "Kaewta Rattanapisit",
        "Theerakarn Srisangsung",
        "Balamurugan Shanmugaraj",
        "Supranee Buranapraditkun",
        "Chutitorn Ketloy",
        "Eakachai Prompetchara",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 2,
    "ref-count": 45,
    "ref-list": [
        "Bats and Coronaviruses",
        "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses",
        "SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far",
        "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
        "The structure and functions of coronavirus genomic 3\u2019 and 5\u2019 ends",
        "Origin and evolution of pathogenic coronaviruses",
        "Prospects for a safe COVID-19 vaccine",
        "A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development",
        "COVID-19 vaccine development: Milestones, lessons and prospects",
        "A systematic review of SARS-CoV-2 vaccine candidates",
        "Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19",
        "Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies",
        "Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection",
        "Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice",
        "Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates",
        "Chapter 11 Selecting an Appropriate Method for Expressing a Recombinant Protein",
        "Addressing demand for recombinant biopharmaceuticals in the COVID-19 era",
        "Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production",
        "Potential Applications of Plant Biotechnology against SARS-CoV-2",
        "Molecular farming\u2014The slope of enlightenment",
        "Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro",
        "Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection",
        "SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates",
        "Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice",
        "SARS-CoV-2 spike protein: A key target for eliciting persistent neutralizing antibodies",
        "Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice",
        "SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen",
        "Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "Therapeutic recombinant protein production in plants: Challenges and opportunities",
        "Contributions of the international plant science community to the fight against infectious diseases in humans\u2014Part 2: Affordable drugs in edible plants for endemic and re-emerging diseases",
        "Contributions of the international plant science community to the fight against human infectious diseases\u2014Part 1: Epidemic and pandemic diseases",
        "Plant-made vaccine antigens and biopharmaceuticals",
        "Plant-Based Vaccines as a Global Vaccination Approach: Current Perspectives",
        "Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins",
        "What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?",
        "Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections",
        "Chapter 12\u2014SARS-CoV-2 Vaccines: Current Trends and Prospects of Developing Plant-Derived Vaccines",
        "Plant-Based Vaccines in Combat against Coronavirus Diseases",
        "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",
        "Plants as Factories for Human Pharmaceuticals: Applications and Challenges",
        "Mechanisms of action of adjuvants"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117011815",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117011815",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co., Ltd."
    ]
}